Maximising efficiency and accuracy in the prospective medical study of the lung cancer-related risk factors and their Impact assessment through the development of a personalised eCRF.
Identification, validation, and characterisation of novel transformation-modifying genetic changes that determine the risk of lung cancer initiation and development.